. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Amantadine/adverse effectsAmantadine/pharmacologyAmantadine/therapeutic useHumansParasympatholytics/adverse effectsParasympatholytics/pharmacologyParasympatholytics/therapeutic useParkinson Disease/drug therapyParkinson Disease/surgeryParkinson Disease, Secondary/chemically induced
Substances: See more » ParasympatholyticsAmantadine
Year: 1972 PMID: 5015332 PMCID: PMC1787626 DOI: 10.1136/bmj.1.5802.741
Source DB: PubMed Journal: Br Med J ISSN: 0007-1447